Published: Guidance, quality standards and advice
Showing 1 to 2 of 2
| Title | Reference number | Published | Last updated |
|---|---|---|---|
| Ceritinib for untreated ALK-positive non-small-cell lung cancer | TA500 | ||
| Ceritinib for previously treated anaplastic lymphoma kinase positive non-small-cell lung cancer | TA395 |